Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HUMAN OVARIAN-CARCINOMA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 120 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kim, SJ; Uehara, H; Karashima, T; Mccarty, M; Shih, N; Fidler, IJ
      Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice

      NEOPLASIA
    2. Kartalou, M; Essigmann, JM
      Mechanisms of resistance to cisplatin

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    3. Downer, JD; Jones, LA; Engelbach, JA; Lich, LL; Mao, W; Carlson, KE; Katzenellenbogen, JA; Welch, MJ
      Comparison of animal models for the evaluation of radiolabeled androgens

      NUCLEAR MEDICINE AND BIOLOGY
    4. Pizzato, M; Blair, ED; Fling, M; Kopf, J; Tomassetti, A; Weiss, RA; Takeuchi, Y
      Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells

      GENE THERAPY
    5. Morgan, RJ; Synold, T; Carr, BI; Doroshow, JH; Womack, EP; Shibata, S; Somlo, G; Raschko, J; Leong, L; McNamara, M; Chow, W; Tetef, M; Margolin, K; Akman, S; Longmate, J
      Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    6. Son, KK; Rosenblatt, J
      Overexpression of protein kinase A-RI alpha reduces lipofection efficiencyof cisplatin-resistant human tumor cells

      CANCER LETTERS
    7. Ikeda, K; Miura, K; Himeno, S; Imura, N; Naganuma, A
      Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    8. Cohen, SM; Lippard, SJ
      Cisplatin: From DNA damage to cancer chemotherapy

      PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 67
    9. Niedner, H; Christen, R; Lin, X; Kondo, A; Howell, SB
      Identification of genes that mediate sensitivity to cisplatin

      MOLECULAR PHARMACOLOGY
    10. Marklund, L; Henriksson, R; Grankvist, K
      Cisplatin-induced apoptosis of mesothelioma cells is affected by potassiumion flux modulator amphotericin B and bumetanide

      INTERNATIONAL JOURNAL OF CANCER
    11. Seidman, R; Gitelman, I; Sagi, O; Horwitz, SB; Wolfson, M
      The role of ERK 1/2 and p38 MAP-kinase pathways in Taxol-induced apoptosisin human ovarian carcinoma cells

      EXPERIMENTAL CELL RESEARCH
    12. Guilbaud, N; Kraus-Berthier, L; Meyer-Losic, F; Pierre, A; Hickman, J
      New approaches in experimental oncology: In search of therapeutic models

      BULLETIN DU CANCER
    13. Obermiller, PS; Tait, DL; Holt, JT
      Gene therapy for carcinoma of the breast - Therapeutic genetic correction strategies

      BREAST CANCER RESEARCH
    14. Jordan, P; Carmo-Fonseca, M
      Molecular mechanisms involved in cisplatin cytotoxicity

      CELLULAR AND MOLECULAR LIFE SCIENCES
    15. Dolo, V; Li, RX; Dillinger, M; Flati, S; Manela, J; Taylor, BJ; Pavan, A; Ladisch, S
      Enrichment and localization of ganglioside G(D3) and caveolin-1 in shed tumor cell membrane vesicles

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
    16. Thompson-Hehir, J; Davies, MPA; Green, JA; Halliwell, N; Joyce, KA; Salisbury, J; Sibson, DR; Vergote, I; Walker, C
      Novel polymerase chain reaction approach for full-coding p53 mutation detection in microdissected archival tumors

      DIAGNOSTIC MOLECULAR PATHOLOGY
    17. Mathias, CJ; Hubers, D; Low, PS; Green, MA
      Synthesis of [99(m)Tc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical

      BIOCONJUGATE CHEMISTRY
    18. Blackwell, JL; Li, H; Gomez-Navarro, J; Dmitriev, I; Krasnykh, V; Richter, CA; Shaw, DR; Alvarez, RD; Curiel, DT; Strong, TV
      Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid

      HUMAN GENE THERAPY
    19. Mueller-Klieser, W
      Tumor biology and experimental therapeutics

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    20. Bacova, G; Hunakova, L; Chorvath, M; Boljesikova, E; Chorvath, B; Sedlak, J; Gabelova, A
      Radiation-induced DNA damage and repair evaluated with 'Comet assay' in human ovarian carcinoma cell lines with different radiosensitivities

      NEOPLASMA
    21. Hunakova, L; Bies, J; Sedlak, J; Duraj, J; Jakubikova, J; Takacsova, X; Novotny, L; Chorvath, B
      Differential sensitivity of ovarian carcinoma cell lines to apoptosis induced by the IMPDH inhibitor benzamide riboside

      NEOPLASMA
    22. Hunakova, L; Chorvath, M; Duraj, J; Bartosova, Z; Sevcikova, L; Sulikova, M; Chovancova, J; Sedlak, J; Chorvath, B; Boljesikova, E
      Radiation-induced apoptosis and cell cycle alterations in human carcinoma cell lines with different radiosensitivities

      NEOPLASMA
    23. Marklund, L; Henriksson, R; Grankvist, K
      Amphotericin B-induced apoptosis and cytotoxicity is prevented by the Na+,K+, 2Cl(-)-cotransport blocker bumetanide

      LIFE SCIENCES
    24. Shen, DW; Goldenberg, S; Pastan, I; Gottesman, MM
      Decreased accumulation of [C-14]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake

      JOURNAL OF CELLULAR PHYSIOLOGY
    25. Konda, SD; Aref, M; Brechbiel, M; Wiener, EC
      Development of a tumor-targeting MR contrast agent using the high-affinityfolate receptor - Work in progress

      INVESTIGATIVE RADIOLOGY
    26. Nicoletti, MI; Colombo, T; Rossi, C; Monardo, C; Stura, S; Zucchetti, M; Riva, A; Morazzoni, P; Donati, MB; Bombardelli, E; D'Incalci, M; Giavazzi, R
      IDN5109, a taxane with oral bioavailability and potent antitumor activity

      CANCER RESEARCH
    27. Rixe, O
      Platinum compounds: mechanisms of action, mechanisms of cellular resistance in human cancers, interactions with ionising radiations, application to carboplatin

      BULLETIN DU CANCER
    28. Satoh, M; Shimada, A; Zhang, BX; Tohyama, C
      Renal toxicity caused by cisplatinum in glutathione-depleted metallothionein-null mice

      BIOCHEMICAL PHARMACOLOGY
    29. Benzinger, P; Martiny-Baron, G; Reusch, P; Siemeister, G; Kley, JT; Marme, D; Unger, C; Massing, U
      Targeting of endothelial KDR receptors with 3G2 immunoliposomes in vitro

      BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
    30. Koelemij, R; Kuppen, PJK; van de Velde, CJH; Fleuren, GJ; Hagenaars, M; Eggermont, AMM
      Bispecific antibodies in cancer therapy, from the laboratory to the clinic

      JOURNAL OF IMMUNOTHERAPY
    31. Rancourt, C; Piche, A; Gomez-Navarro, J; Wang, MH; Alvarez, RD; Siegel, GP; Fuller, GM; Jones, SA; Curiel, DT
      Interleukin-6 modulated conditionally replicative adenovirus as an antitumor/cytotoxic agent for cancer therapy

      CLINICAL CANCER RESEARCH
    32. Raaphorst, GP; Wilkins, DE; Mao, JP; Miao, JC; E, C; Ng, CE
      Evaluation of cross-resistance between responses to cisplatin, hyperthermia, and radiation in human glioma cells and eight clones selected for cisplatin resistance

      RADIATION ONCOLOGY INVESTIGATIONS
    33. Li, W; Shen, F; Weber, G
      Ribavirin and quercetin synergistically downregulate signal transduction and are cytotoxic in human ovarian carcinoma cells

      ONCOLOGY RESEARCH
    34. Gomez-Navarro, J; Curiel, DT; Douglas, JT
      Gene therapy for cancer

      EUROPEAN JOURNAL OF CANCER
    35. Saretzki, G; Sitte, N; Merkel, U; Wurm, RE; von Zglinicki, T
      Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments

      ONCOGENE
    36. Nishioka, Y; Kobayashi, K; Sagae, S; Sugimura, M; Ishioka, S; Nagata, M; Terasawa, K; Tokino, T; Kudo, R
      Mutational analysis of STK11 gene in ovarian carcinomas

      JAPANESE JOURNAL OF CANCER RESEARCH
    37. Sagae, S; Kobayashi, K; Nishioka, Y; Sugimura, M; Ishioka, S; Nagata, M; Terasawa, K; Tokino, T; Kudo, R
      Mutational analysis of beta-catenin gene in Japanese ovarian carcinomas: Frequent mutations in endometrioid carcinomas

      JAPANESE JOURNAL OF CANCER RESEARCH
    38. Amoroso, AR; Alpaugh, RK; Barth, MW; McCall, AM; Weiner, LM
      Production and characterization of mice transgenic for the A and B isoforms of human Fc gamma RIII

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    39. Siegsmund, MJ; Marx, C; Seemann, O; Schummer, B; Steidler, A; Toktomambetova, L; Kohrmann, KU; Rassweiler, J; Alken, P
      Cisplatin-resistant bladder carcinoma cells: enhanced expression of metallothioneins

      UROLOGICAL RESEARCH
    40. Weber, G; Shen, F; Yang, HY; Prajda, N; Li, W
      Regulation of signal transduction activity in normal and cancer cells

      ANTICANCER RESEARCH
    41. Ferguson, PJ; Currie, C; Vincent, MD
      Enhancement of platinum-drug cytotoxicity in a human head and neck squamous cell carcinoma line and its platinum-resistant variant by liposomal amphotericin band phospholipase A2-II

      DRUG METABOLISM AND DISPOSITION
    42. Vukovic, L; Osmak, M
      Reversal of carboplatin resistance in human laryngeal carcinoma cells

      NEOPLASMA
    43. Heise, CC; Williams, AM; Xue, S; Propst, M; Kirn, DH
      Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy

      CANCER RESEARCH
    44. Ross, JF; Wang, H; Behm, FG; Mathew, P; Wu, M; Booth, R; Ratnam, M
      Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia

      CANCER
    45. Fonseca, MJ; Haisma, HJ; Klaasen, S; Vingerhoeds, MH; Storm, G
      Design of immuno-enzymosomes with maximum enzyme targeting capability: effect of the enzyme density on the enzyme targeting capability and cell binding properties

      BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
    46. Mastrobattista, E; Storm, G; van Bloois, L; Reszka, R; Bloemen, PGM; Crommelin, DJA; Henricks, PAJ
      Cellular uptake of liposomes targeted to intercellular adhesion molecule-1(ICAM-1) on bronchial epithelial cells

      BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
    47. RAAPHORST GP; MAIO J; NG CE; STEWART DJ
      CONCOMITANT TREATMENT WITH MILD HYPERTHERMIA, CISPLATIN AND LOW DOSE-RATE IRRADIATION IN HUMAN OVARIAN-CANCER CELLS SENSITIVE AND RESISTANTTO CISPLATIN

      Oncology Reports
    48. MATHIAS CJ; GREEN MA
      A KIT FORMULATION FOR PREPARATION OF [IN-111]IN-DTPA-FOLATE, A FOLATE-RECEPTOR-TARGETED RADIOPHARMACEUTICAL

      Nuclear medicine and biology
    49. LI W; WEBER G
      SYNERGISTIC ACTION OF TIAZOFURIN AND GENISTEIN IN HUMAN OVARIAN-CARCINOMA CELLS

      Oncology research
    50. JOZAN S; COURTADE M; MATHIEUBOUE A; LOCHON I; BUGAT R
      CYTOTOXIC EFFECT OF INTERFERON-ALPHA-2A IN COMBINATION WITH ALL-TRANS-RETINOIC ACID OR CISPLATIN IN HUMAN OVARIAN-CARCINOMA CELL-LINES

      Anti-cancer drugs
    51. RAYMOND E; CHANEY SG; TAAMMA A; CVITKOVIC E
      OXALIPLATIN - A REVIEW OF PRECLINICAL AND CLINICAL-STUDIES

      Annals of oncology
    52. SEDLAK J; HUNAKOVA L; CHORVATH M; SULIKOVA M; NOVOTNY L; BOLJESIKOVA E; ZEILLINGER R; CHORVATH B
      RESISTANCE OF HUMAN MULTIDRUG-RESISTANT NEOPLASTIC CELL-LINES TO PACLITAXEL-INDUCED-RADIOSENSITIZATION IS REDUCED BY THE NONIMMUNOSUPPRESSIVE CYCLOSPORINE ANALOG SDZ PSC-833

      Anticancer research
    53. KROESEN BJ; HELFRICH W; MOLEMA G; DELEIJ L
      BISPECIFIC ANTIBODIES FOR TREATMENT OF CANCER IN EXPERIMENTAL ANIMAL-MODELS AND MAN

      Advanced drug delivery reviews
    54. MATHIAS CJ; WANG S; WATERS DJ; TUREK JJ; LOW PS; GREEN MA
      INDIUM-111-DTPA-FOLATE AS A POTENTIAL FOLATE-RECEPTOR-TARGETED RADIOPHARMACEUTICAL

      The Journal of nuclear medicine
    55. SHARP SY; SMITH V; HOBBS S; KELLAND LR
      LACK OF A ROLE FOR MRP1 IN PLATINUM DRUG-RESISTANCE IN HUMAN OVARIAN-CANCER CELL-LINES

      British Journal of Cancer
    56. LANZI C; PEREGO P; SUPINO R; ROMANELLI S; PENSA T; CARENINI N; VIANO I; COLANGELO D; LEONE R; APOSTOLI P; CASSINELLI G; GAMBETTA RA; ZUNINO F
      DECREASED DRUG ACCUMULATION AND INCREASED TOLERANCE TO DNA-DAMAGE IN TUMOR-CELLS WITH A LOW-LEVEL OF CISPLATIN RESISTANCE

      Biochemical pharmacology
    57. LUITEN RM; WARNAAR SO; SANBORN D; LAMERS CHJ; BOLHUIS RLH; LITVINOV SV; ZURAWSKI VR; CONEY LR
      CHIMERIC BISPECIFIC OC TR MONOCLONAL-ANTIBODY MEDIATES LYSIS OF TUMOR-CELLS EXPRESSING THE FOLATE-BINDING PROTEIN (MOV18) AND DISPLAYS DECREASED IMMUNOGENICITY IN PATIENTS/

      Journal of immunotherapy
    58. BILBAO G; GOMEZNAVARRO J; CONTRERAS JL; CURIEL DT
      ADVANCES IN ADENOVIRAL VECTORS FOR CANCER GENE-THERAPY

      Expert opinion on therapeutic patents
    59. BARON PL; GATES CE; REED CE; DIKEMAN RLD; DROSIEKO JJ; PASSMORE RN; BROMBERG JS; WILLINGHAM MC
      P53 OVEREXPRESSION IN SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS

      Annals of surgical oncology
    60. JOH K; KANETSUNA Y; TAKADA K; OHKAWA K
      A MONOCLONAL-ANTIBODY CF703 RAISED AGAINST HUMAN FETAL LUNG RECOGNIZES A NOVEL ONCO-FETAL MUCIN

      International journal of oncology
    61. SON K
      CELLULAR-RESISTANCE TO OXIDATIVE STRESS ENHANCES IN-VITRO AND IN-SITULIPOSOME-MEDIATED GENE-TRANSFER

      International journal of oncology
    62. HOFS HP; WAGENER TDJ; DEVALKBAKKER V; VANRENNES H; DOESBURG WH; OTTENHEIJM HCJ; DEGRIP WJ
      THE EFFECT OF ETHYLDESHYDROXY-SPARSOMYCIN AND CISPLATIN ON THE INTRACELLULAR GLUTATHIONE LEVEL AND GLUTATHIONE-S-TRANSFERASE ACTIVITY

      Anti-cancer drugs
    63. BARBOULE N; CHADEBECH P; BALDIN V; VIDAL S; VALETTE A
      INVOLVEMENT OF P21 IN MITOTIC EXIT AFTER PACLITAXEL TREATMENT IN MCF-7 BREAST ADENOCARCINOMA CELL-LINE

      Oncogene
    64. ROBBINS KT; KUMAR P; REGINE WF; WONG FSH; WEIR AB; FLICK P; KUN LE; PALMER R; MURRAY T; FONTANESI J; FERGUSON R; THOMAS R; HARTSELL W; PAIG CU; SALAZAR G; NORFLEET L; HANCHETT CB; HARRINGTON V; NIELL HB
      EFFICACY OF TARGETED SUPRADOSE CISPLATIN AND CONCOMITANT RADIATION-THERAPY FOR ADVANCED HEAD AND NECK-CANCER - THE MEMPHIS EXPERIENCE

      International journal of radiation oncology, biology, physics
    65. JACOBS N; MAZZONI A; MEZZANZANICA D; NEGRI DRM; VALOTA O; COLNAGHI MI; MOUTSCHEN MP; BONIVER J; CANEVARI S
      EFFICIENCY OF T-CELL TRIGGERING BY ANTI-CD3 MONOCLONAL-ANTIBODIES (MAB) WITH POTENTIAL USEFULNESS IN BISPECIFIC MAB GENERATION

      Cancer immunology and immunotherapy
    66. LOOK KY; MOORE DH; SUTTON GP; PRAJDA N; ABONYI M; WEBER G
      INCREASED THYMIDINE KINASE AND THYMIDYLATE SYNTHASE ACTIVITIES IN HUMAN EPITHELIAL OVARIAN-CARCINOMA

      Anticancer research
    67. CASALINI P; LUISON E; MENARD S; COLNAGHI MI; PAGANELLI G; CANEVARI S
      TUMOR PRETARGETING - ROLE OF AVIDIN STREPTAVIDIN ON MONOCLONAL-ANTIBODY INTERNALIZATION/

      The Journal of nuclear medicine
    68. COLVIN OM
      DRUG-RESISTANCE IN THE TREATMENT OF SARCOMAS

      Seminars in oncology
    69. PEREGO P; VANDEWEGHE J; OW DW; HOWELL SB
      ROLE OF DETERMINANTS OF CADMIUM SENSITIVITY IN THE TOLERANCE OF SCHIZOSACCHAROMYCES-POMBE TO CISPLATIN

      Molecular pharmacology
    70. CALIARO MJ; VITAUX P; LAFON C; LOCHON I; NEHME A; VALETTE A; CANAL P; BUGAT R; JOZAN S
      MULTIFACTORIAL MECHANISM FOR THE POTENTIATION OF CISPLATIN (CDDP) CYTOTOXICITY BY ALL-TRANS-RETINOIC ACID (ATRA) IN HUMAN OVARIAN-CARCINOMACELL-LINES

      British Journal of Cancer
    71. TIBILETTI MG; BERNASCONI B; TABORELLI M; FURLAN D; FABBRI A; FRANCHI M; TARAMELLI R; TRUBIA M; CAPELLA C
      INVOLVEMENT OF CHROMOSOME-6 IN ENDOMETRIAL CANCER

      British Journal of Cancer
    72. MARVERTI G; ANDREWS PA
      STIMULATION OF CIS-DIAMMINEDICHLOROPLATINUM(II) ACCUMULATION BY MODULATION OF PASSIVE PERMEABILITY WITH GENISTEIN - AN ALTERED RESPONSE IN ACCUMULATION-DEFECTIVE RESISTANT CELLS

      Clinical cancer research
    73. SHALINSKY DR; BISCHOFF ED; GREGORY ML; LAMPH WW; HEYMAN RA; HAYES JS; THOMAZY V; DAVIES PJA
      ENHANCED ANTITUMOR EFFICACY OF CISPLATIN IN COMBINATION WITH ALRT1057(9-CIS RETINOIC ACID) IN HUMAN ORAL SQUAMOUS CARCINOMA XENOGRAFTS IN NUDE-MICE

      Clinical cancer research
    74. SON K; HUANG L
      FACTORS INFLUENCING THE DRUG SENSITIZATION OF HUMAN TUMOR-CELLS FOR IN-SITU LIPOFECTION

      Gene therapy
    75. AUDISIO RA; VERONESI P; MAISONNEUVE P; CHIAPPA A; ANDREONI B; BOMBARDIERI E; GERAGHTY JG
      CLINICAL RELEVANCE OF SEROLOGICAL MARKERS IN THE DETECTION AND FOLLOW-UP OF PANCREATIC ADENOCARCINOMA

      Surgical oncology
    76. BELVEDERE G; IMPERATORI L; DAMIA G; TAGLIABUE G; MEIJER C; DEVRIES EGE; DINCALCI M
      IN-VITRO AND IN-VIVO CHARACTERIZATION OF LOW-RESISTANT MOUSE RETICULOSARCOMA (M5076) SUBLINES OBTAINED AFTER PULSE AND CONTINUOUS EXPOSURE TO CISPLATIN

      European journal of cancer
    77. CHAO CCK
      MOLECULAR-BASIS OF CIS-DIAMMINEDICHLOROPLATINUM(II) RESISTANCE - A REVIEW

      Journal of the Formosan Medical Association
    78. YANG JL; FERNANDES DJ; WHEELER KT; CAPIZZI RL
      PALA ENHANCEMENT OF BROMODEOXYURIDINE INCORPORATION INTO DNA INCREASES RADIATION CYTOTOXICITY TO HUMAN OVARIAN ADENOCARCINOMA CELLS

      International journal of radiation oncology, biology, physics
    79. BOLHUIS RLH; HOOGENBOOM HR; GRATAMA JW
      TARGETING OF PERIPHERAL-BLOOD T-LYMPHOCYTES

      Perspectives in mathematical logic
    80. JACOBS N; GREIMERS R; MAZZONI A; TREBAK M; SCHAAFLAFONTAINE N; BONIVER J; MOUTSCHEN RP
      FURTHER CHARACTERIZATION OF CYTOTOXIC T-CELLS GENERATED BY SHORT-TERMCULTURE OF HUMAN PERIPHERAL-BLOOD LYMPHOCYTES WITH INTERLEUKIN-2 AND ANTI-CD3 MAB

      Cancer immunology and immunotherapy
    81. WEBER G; SHEN F; PRAJDA N; YEH YA; YANG HY; HERENYIOVA M; LOOK KY
      INCREASED SIGNAL-TRANSDUCTION ACTIVITY AND DOWN-REGULATION IN HUMAN CANCER-CELLS

      Anticancer research
    82. JOST CR; TITUS JA; KURUCZ I; SEGAL DM
      A SINGLE-CHAIN BISPECIFIC FV(2) MOLECULE PRODUCED IN MAMMALIAN-CELLS REDIRECTS LYSIS BY ACTIVATED CTL

      Molecular immunology
    83. MATHIAS CJ; WANG S; LEE RJ; WATERS DJ; LOW PS; GREEN MA
      TUMOR-SELECTIVE RADIOPHARMACEUTICAL TARGETING VIA RECEPTOR-MEDIATED ENDOCYTOSIS OF GALLIUM-67-DEFEROXAMINE-FOLATE

      The Journal of nuclear medicine
    84. ROBBINS KT; HOFFMAN RM
      DECADOSE EFFECTS OF CISPLATIN ON SQUAMOUS-CELL CARCINOMA OF THE UPPERAERODIGESTIVE TRACT .1. HISTOCULTURE EXPERIMENTS

      The Laryngoscope
    85. AEBI S; KURDIHAIDAR B; GORDON R; CENNI B; ZHENG H; FINK D; CHRISTEN RD; BOLAND CR; KOI M; FISHEL R; HOWELL SB
      LOSS OF DNA MISMATCH REPAIR IN ACQUIRED-RESISTANCE TO CISPLATIN

      Cancer research
    86. CHANEY SG; SANCAR A
      DNA-REPAIR - ENZYMATIC MECHANISMS AND RELEVANCE TO DRUG RESPONSE

      Journal of the National Cancer Institute
    87. BAKACS T; LEE J; MORENO MB; ZACHARCHUK CM; COLE MS; TSO JY; PAIK CH; WARD JM; SEGAL DM
      A BISPECIFIC ANTIBODY PROLONGS SURVIVAL IN MICE BEARING LUNG METASTASES OF SYNGENEIC MAMMARY ADENOCARCINOMA

      International immunology
    88. HEIKE Y; TAKAHASHI M; OHIRA T; ARIOKA H; FUNAYAMA Y; NISHIO K; OGASAWARA H; SAIJO N
      IN-VIVO SCREENING MODELS OF CISPLATIN-RESISTANT HUMAN LUNG-CANCER CELL-LINES USING SCID MICE

      Cancer chemotherapy and pharmacology
    89. MORENO MB; TITUS JA; COLE MS; TSO JY; LE N; PAIK CH; BAKACS T; ZACHARCHUK CM; SEGAL DM; WUNDERLICH JR
      BISPECIFIC ANTIBODIES RETARGET MURINE T-CELL CYTOTOXICITY AGAINST SYNGENEIC BREAST-CANCER IN-VITRO AND IN-VIVO

      Cancer immunology and immunotherapy
    90. CORVER WE; CORNELISSE CJ; HERMANS J; FLEUREN GJ
      LIMITED LOSS OF 9 TUMOR-ASSOCIATED SURFACE ANTIGENIC DETERMINANTS AFTER TRYPTIC CELL-DISSOCIATION

      Cytometry
    91. BORRAS G; MOLINA R; XERCAVINS J; BALLESTA A; IGLESIAS J
      TUMOR-ANTIGENS CA-19.9, CA-125, AND CEA IN CARCINOMA OF THE UTERINE CERVIX

      Gynecologic oncology
    92. YANG LY; LI L; KEATING MJ; PLUNKETT W
      ARABINOSYL-2-FLUOROADENINE AUGMENTS CISPLATIN CYTOTOXICITY AND INHIBITS CISPLATIN-DNA CROSS-LINK REPAIR

      Molecular pharmacology
    93. NAREDI P; HEATH DD; ENNS RE; HOWELL SB
      CROSS-RESISTANCE BETWEEN CISPLATIN, ANTIMONY POTASSIUM TARTRATE, AND ARSENITE IN HUMAN TUMOR-CELLS

      The Journal of clinical investigation
    94. NEGRI DRM; TOSI E; VALOTA O; FERRINI S; CAMBIAGGI A; SFORZINI S; SILVANI A; RUFFINI PA; COLNAGHI MI; CANEVARI S
      IN-VITRO AND IN-VIVO STABILITY AND ANTITUMOR EFFICACY OF AN ANTI-EGFRANTI-CD3 F(AB')(2) BISPECIFIC MONOCLONAL-ANTIBODY

      British Journal of Cancer
    95. NICOLETTI MI; LUCCHINI V; DINCALCI M; GIAVAZZI R
      COMPARISON OF PACLITAXEL AND DOCETAXEL ACTIVITY ON HUMAN OVARIAN-CARCINOMA XENOGRAFTS

      European journal of cancer
    96. MATSUOKA T; UOZUMI T; KURISU K; MAEDA H; KAWAMOTO K; MONDEN S
      ANTITUMOR EFFECTS OF HUMAN RECOMBINANT MACROPHAGE-COLONY-STIMULATING FACTOR AGAINST RAT-BRAIN TUMORS

      Biotherapy
    97. STEWART DJ; MOLEPO JM; EAPEN L; MONTPETIT VAJ; GOEL R; WONG PTT; POPOVIC P; TAYLOR KD; RAAPHORST GP
      CISPLATIN AND RADIATION IN THE TREATMENT OF TUMORS OF THE CENTRAL-NERVOUS-SYSTEM - PHARMACOLOGICAL CONSIDERATIONS AND RESULTS OF EARLY STUDIES

      International journal of radiation oncology, biology, physics
    98. JENNERWEIN M; ANDREWS PA
      DRUG ACCUMULATION AND DNA PLATINATION IN CELLS EXPOSED TO AQUATED CISPLATIN SPECIES

      Cancer letters
    99. WEITMAN SD; FRAZIER KM; KAMEN BA
      THE FOLATE RECEPTOR IN CENTRAL-NERVOUS-SYSTEM MALIGNANCIES OF CHILDHOOD

      Journal of neuro-oncology
    100. RENNER C; JUNG W; SAHIN U; DENFELD R; POHL C; TRUMPER L; HARTMANN F; DIEHL V; VANLIER R; PFREUNDSCHUH M
      CURE OF XENOGRAFTED HUMAN TUMORS BY BISPECIFIC MONOCLONAL-ANTIBODIES AND HUMAN T-CELLS

      Science


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/07/20 alle ore 05:29:58